The first patient has been enrolled in the pivotal ARID II trial, which is designed to investigate the safety and effectiveness of Voro Urologic Scaffold in adult men with prostate cancer undergoing ...

“When we see the data that says that robotic prostatectomy patients take over two weeks of recovery, on average, to feel like a TULSA patient does the day after their procedure, we can ...